Navigation Links
Molecule shows effectiveness against drug-resistant myeloma
Date:9/10/2012

BOSTONA molecule that targets the cell's machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers at Dana-Farber Cancer Institute have found.

In a study published online by the journal Cancer Cell, the investigators report that the small molecule P5091 triggered apoptosis -- programmed cell death -- in drug-resistant myeloma cells grown in the laboratory and in animals. The anti-myeloma effect was even more powerful when researchers combined P5091 with other therapies.

"Velcade was one of the first of a class of drugs known as proteasome inhibitors to be approved by the U.S. Food and Drug Administration for multiple myeloma treatment," says Dharminder Chauhan, PhD, lead author of the paper with Ze Tian, PhD, both of Dana-Farber. "While Velcade is successful in many patients with multiple myeloma, it often loses its effectiveness over time, which prompted us to seek other drug targets."

The proteasome acts as a cell's "garbage disposal," chewing up and disposing of unwanted proteins. Inhibiting the proteasome causes an accumulation of waste proteins that spurs cancer cell death.

The proteasome also is part of a larger mechanism known as the ubiquitin proteasome system, or UPS. The system functions by in two manners: It can attach small proteins known as ubiquitins to cell proteins, thereby ticketing those proteins for disposal by the proteasome; or it can remove ubiquitins, thus sparing the proteins from disposal.

"Dysfunction of the UPS has been linked to the development of many human diseases, including cancer, and is a valid target for therapy," Chauhan remarks.

A variety of enzymes help affix or remove ubiquitin from proteins. In the current study, investigators focused on a remover -- a "deubiquitylator" known as USP7. Studies have shown that USP7 acts on many cancer-related proteins: by breaking down proteins that r
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Molecule movements that make us think
2. Prions in the brain eliminated by homing molecules
3. Researchers identify a life-and-death molecule on chronic leukemia cells
4. Inhibitors of shuttle molecule show promise in acute leukemia
5. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
6. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
7. Molecule found that inhibits recovery from stroke
8. Wellesley study shows income inequality a key factor in high US teen births
9. Invasive heart test being dramatically overused, Stanford study shows
10. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
11. Lung Cancer Screening Might Pay Off, Analysis Shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Molecule shows effectiveness against drug-resistant myeloma
(Date:12/25/2014)... Woodland Hills, California (PRWEB) December 25, 2014 ... in her home in Woodland Hills, California after an ... Harris passed away on Christmas Eve evening in her ... battle with aggressive metastatic breast cancer. ... International for over forty years, she pioneered and championed ...
(Date:12/25/2014)... updated its blog to provide professional shopping tips on wedding and ... LunaDress.co.uk come with big discounts, up to 80 percent off. , ... to be a most exciting memory and can show off a ... a wedding. On the updated fashion blog, ladies can now find ... day . , Going out with friends to a party is ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... WEDNESDAY, Dec. 24, 2014 (HealthDay News) -- Among early ... treatment, less than half of one percent will eventually ... new analysis reveals. The finding comes from a ... between 1998 and 2007, and it suggests that the ... double what experts had previously thought. "The frequency ...
(Date:12/25/2014)... AngelWeddingDress.com tries its best to translate the experience of ... has introduced its new collection of 2015 prom dresses, ... new prom outfits are guaranteed to contain the perfect ... specially designed for 2015. Anyone who wants to buy ... website before Jan. 26, 2015, the deadline of the ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... adults want to avoid looking older than their actual age, ... does not necessarily point to poor health. The study found ... older than their actual age before assumptions about their health ... physicians describe their patients to other physicians, they often include ...
... , FRIDAY, Nov. 5 (HealthDay News) -- New genetic ... who carry a particular gene mutation are particularly well-skilled ... apparent link between a specific variation of the so-called ... the first hard evidence to suggest that there could ...
... 2010) Nine years ago, scientists at Cedars-Sinai,s Maxine ... the molecular makeup of the most aggressive type of ... that a specific protein called laminin-411 plays a major ... vessels to support its growth and spread. But technology ...
... research group led by Prof. Ryusuke Kakigi and Dr. ... Prof. Masami K Yamaguchi (Chuo University) found that the ... sulcus (STS) when processing positive (happy) and negative (angry) ... in NeuroImage . Near infrared spectroscopy (NIRS) ...
... HealthDay Reporter , THURSDAY, Nov. 4 (HealthDay News) -- ... at a slight increased risk for a hemorrhagic stroke, researchers ... can protect against heart disease, while others have found that, ... In the United States, an estimated 13 percent of the ...
... , THURSDAY, Nov. 4 (HealthDay News) -- ... heavy clothes to keep infants warm can lead to ... death syndrome (SIDS), U.S. experts warn. Infants are ... of their body temperature. Research has shown that multiple ...
Cached Medicine News:Health News:Looking older than your age may not be a sign of poor health: Study 2Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:Cedars-Sinai 'nano-drug' hits brain-tumor target found in 2001 2Health News:Cedars-Sinai 'nano-drug' hits brain-tumor target found in 2001 3Health News:Infants' hemodynamic responses to happy and angry facial expressions 2Health News:Vitamin E May Pose Slight Bleeding-Stroke Risk 2Health News:Vitamin E May Pose Slight Bleeding-Stroke Risk 3Health News:Overheating in Infants Can Lead to SIDS, Experts Warn 2
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, Inc., ... over-the-counter (OTC) medicinal and healthcare products, announced it received ... H, a hemp-based, advanced headache relief product, for planned ... Colorado , Washington State ... With the MigraPure H Advanced headache relief gel ...
(Date:12/24/2014)...  Advanced Medical Isotope Corporation ("AMIC") (OTCQB: ADMD), a ... development of brachytherapy devices and medical isotopes for ... has filed a de novo submission ... marketing clearance for its patented Y-90 RadioGel(TM) device ... Drug and Cosmetic Act (the "Act").  ...
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
Breaking Medicine Technology:PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... Group (MRG), the global authority on medical technology ... research data for multiple geographies, including the US, ... MRG,s peripheral vascular reports cover minimally invasive ... stenting, percutaneous transluminal balloon angioplasty, and synthetic surgical ...
... RO, ROG; OTCQX: RHHBY) and study investigators from Harvard ... the PROTECT ( Pr o-BNP O utpatient ... T herapy) trial, a strategy of NT-proBNP guided heart ... in total cardiovascular events, the primary composite endpoint of ...
Cached Medicine Technology:New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group 2NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events 2NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events 3
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
Steroid eluting pacemaker leads...
Medicine Products: